• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

BioStartup Advice

  • Simulations
        • Simulations


        • BioStartup Advice: A Day in the Life
        • Stages of Starting a Biotech Business


        • Explore Motives & Skills Needed
        • Develop a Business Plan
        • Set Up Your Business
  • Topics
        • Topics


        • Exploring Entrepreneurship Possibilities:

        • Women Life Scientists as Entrepreneurs
        • Communication Skills for Women Scientists
        • Contemplating Entrepreneurship
        • Learning about Entrepreneurship:

        • Early Funding
        • Starting a Life Science Business
        • Basics of Intellectual Property
  • About
    • About BioStartup
    • About Us
    • Contact
  • Self-Check
  • Resources
    • Glossary
    • Blog
          • Topics:

          • Category:

          • Sort By:

          • Clear Filter
        • Resources | Tips | Case Examples
Home › Topics › Starting a Life Science Business › Business and Commercialization Plan

Other Post-SBIR Commercialization Support

Topics Starting a Life Science Business Business and Commercialization Plan Other Post-SBIR Commercialization Support

Monique Aster, Phd

Case Name: Monique Aster, PhD

Background: With funding from an NIH SBIR grant, Monique has been using gene therapy to develop a treatment for a metabolic disease that runs in her family. She recently submitted her first Phase II annual report to Dr. Jane Stevens, her project officer at the NIH.

  • Email

Monique Aster, Phd

Jane Stevens <stevensj@nihemail.com>

to aster.monique@email.com

Dr. Aster,
I was excited to read about your progress in your first-year report for your Phase II SBIR grant.

It’s not too soon to think about Phase III development. The NIH has several programs that may be beneficial to support your commercialization and to get you to an inception point. The IIB Bridge award, for example, helps support the next phase of development after a Phase II SBIR award and commercialization.

If you haven’t looked into them, you should check out NCAT’s Therapeutics for Rare and Neglected Diseases (TRND) program. They support the preclinical development of therapeutic candidates for rare or neglected disorders. Another program, Bridging Interventional Development Gaps, supplies resources and offers consultation with intramural scientists to promising therapeutic candidates that might help you bridge the gap between SBIR funding and filing with the FDA. You may want to pursue them as you develop this treatment.

Let me know if you have any questions as you prepare your proposal.

Jane Stevens, PhD
SBIR Office NIH Agency

Other NIH Post-SBIR Commercialization Support

  • Education Programs on Commercialization
    • Concept to Clinic: Commercialization Innovation (C3i) Program – The C3i Program provides specialized business frameworks and essential tools for the successful early-stage translation of biomedical technologies from the lab (concept) to the market (clinical) to meet a need. The program guides investigators to better understand their innovation’s commercial viability through mentoring and a 24-week curriculum.
  • Funding and Support Programs on Transitioning to the Marketplace
    • Commercial Readiness Program (CRP) – This is an NIH program that supports the transition from Phase II to Phase III, that is, to go from being SBIR-funded to the marketplace. It provides training in developing tailored market entry strategies, building strategic partnerships, developing FDA regulator and reimbursement paths, creating financing strategies, and understanding intellectual property.
    • NIH Innovator Support – A free business resource for small business awardees, NIH Innovator Support provides a team of entrepreneurs in residence assistance with the commercialization of their technology and achieving success in the market.
  • NIH Partnering and Investment Opportunities – This provides information on partnering with the NIH. See FDA Technology Transfer for similar opportunities with the FDA.
  • IIB Bridge Award: This award comes after an SBIR Phase II grant. It helps bridge the gap in funding between the SBIR program and commercialization. Funds help continue the development needed to bring the product to market, including technology validation and clinical translation. Funding is provided for two to three years. NCI IIB, NHLBI IIB, NSF IIB.
Previous Article
Back to Sub-Topic
Next Article

Primary Sidebar

Topic Home Expand All
Intro to Starting a Life Science Business
3 Articles
Overview of Starting a Life Sciences Business
Evaluate Your Business Skills
Finding a Sound Business Idea
Early Market Research
3 Articles
Case Example: Leslie Bowen, Early Market Research
Market Research Before Starting a Business
Tips for Biomedical Market Research
Business and Commercialization Plan
9 Articles
Writing a Business Plan
Develop a Reimbursement Strategy
Technical and Business Assistance and Other Commercialization Support
Case Example: Commercialization Advice
Other Post-SBIR Commercialization Support
Planning Your Research Environment
Technology Readiness Level
Design, Prototype, Testing, Manufacturing
Tips on Planning from Successful Biotech Entrepreneurs
Financial Skills, Planning, & Investors
6 Articles
Financial Planning
Tackling Financial Risk
Equity and Shares
Sources of Capital for Small Businesses
Case Example: Learning Investor Basics
Entrepreneur Financial Skills and Resources
Registering Your Business
3 Articles
Business Name, Tax IDs, and Insurance
Registrations for Your Business
Industry-Specific Requirements, Licenses, and Permits
Your Business Governance
4 Articles
Select a Business Structure
Cofounders, Partners, and Founding Team
Board of Directors
Roles You Can Play in the Business
Return to Starting a Life Science Business

This project is funded by National Institute of General Medical Sciences (Grants 1R43 GM131458-01 & 2R GM131458-02)


  • Contact
  • Copyright & Reproduction Guidelines
  • Privacy Policy
  • Terms of Service
  • Technology Requirements
  • 508 Compliance

Footer

a product of
Health Impact Studio
a division of Clinical Tools, Inc
  • Simulations
  • Contact
  • About
  • Blog
  • Facebook
  • LinkedIn
  • Twitter
feedback@clinicaltools.com

101 A Market St Chapel Hill, NC 27516
919-960-8118

We're Hiring!

Join the Development Team!

© 2023 · Clinical Tools, Inc · Log in

Forgot Password?
Register New Account
Sign up for our Newsletter!

  • Hidden

Register

"*" indicates required fields

Name*
Consent

Login
Accessing this topic requires a login. Please enter your credentials below!

Lost Your Password?
Register
Don't have an account? Register one!
Register an Account

Registration confirmation will be emailed to you.